Research
Neural
Tirzepatide dose-dependently reduced voluntary alcohol consumption and prevented binge and relapse-like drinking.
Tirzepatide may help in managing alcohol use disorder by reducing consumption and preventing relapse.
StrongSupportsmedium confidence
Subsequently, this GLP-1R/GIPR agonist dose-dependently reduced voluntary alcohol consumption (P < 0.001), prevented binge (P < 0.01) and relapse-like drinking (P < 0.001).
Why this rating
Supported by multiple behavioral assays.
Source
Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents
Christian E. Edvardsson et al. · EBioMedicine · 2026
DOI 10.1016/j.ebiom.2025.106119
otherCited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Tirzepatide effectively attenuated the rewarding properties of alcohol, measured through locomotor stimulation, conditioned place preference, and accumbal dopamine release.Strong
- Tirzepatide affected metabolic parameters including body weight, adipose tissue mass, hepatic triglycerides, and circulating pro-inflammatory cytokines.Strong
Related findings · Neural
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →